Anti-glomerular basement membrane disease with IgA nephropathy: A case report

Table 2 Characteristics of some cases of coexistence of anti-glomerular basement membrane disease and IgA nephropathy in recent 5 years

Ref.	Sex (Male/Female)	Age (yr)	Initial serum creatinine (μmol/L)	Pulmonary hemorrhage	Gross hematuria	Anti-GBM antibody	Crescent ratio	Treatment methods	Treatment outcome
Annamalai et al[14], 2021	Female	22	168.53 increase to 282.88 in one week	Negative	Positive	96 U/mL	7/10	IV Methyl-PD + oral-PD	Improved, nondialysis-dependent renal dysfunction
Suh et al[15], 2019	Female	38	57.46 increase to 481.78 in three months	Negative	Positive	187.2 U/mL	11/16	IV Methyl-PD + oral-PD + IV cyclophsphamide	Improved, nondialysis-dependent renal dysfunction
Kojima et al[13], 2019	Female	66	91.62 increase to 400.45 in one month	Negative	Negative	116 IU/mL	18/25	HD + PE + IV Methyl-PD + oral-PD	HD
Xu et al[16], 2016	Female	50	157 increase to 220 in ten days	Negative	Positive	258.3 EU/mL	16/18	IV Methyl-PD + Oral-PD + Mycophenolate mofetil	Improved, nondialysis-dependent renal dysfunction
This case	Male	49	133 without rapid progress	Negative	Negative	68 RU/mL	21/29	IV Methyl-PD + oral-PD + IV cyclophsphamide	Improved, nondialysis-dependent renal dysfunction

GBM: Glomerular basement membrane; IV: Intravenous injection; Methyl-PD: Methylprednisolone; oral-PD: oral prednisolone; PE: Plasma exchange; HD: Hemodialysis.